| UniProt ID | TOP3A_HUMAN | |
|---|---|---|
| UniProt AC | Q13472 | |
| Protein Name | DNA topoisomerase 3-alpha | |
| Gene Name | TOP3A | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1001 | |
| Subcellular Localization | ||
| Protein Description | Releases the supercoiling and torsional tension of DNA introduced during the DNA replication and transcription by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(5'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 3'-OH DNA strand. The free DNA strand then undergoes passage around the unbroken strand thus removing DNA supercoils. Finally, in the religation step, the DNA 3'-OH attacks the covalent intermediate to expel the active-site tyrosine and restore the DNA phosphodiester backbone. Essential component of the RMI complex, a complex that plays an important role in the processing of homologous recombination intermediates to limit DNA crossover formation in cells. Has DNA decatenation activity.. | |
| Protein Sequence | MIFPVARYALRWLRRPEDRAFSRAAMEMALRGVRKVLCVAEKNDAAKGIADLLSNGRMRRREGLSKFNKIYEFDYHLYGQNVTMVMTSVSGHLLAHDFQMQFRKWQSCNPLVLFEAEIEKYCPENFVDIKKTLERETRQCQALVIWTDCDREGENIGFEIIHVCKAVKPNLQVLRARFSEITPHAVRTACENLTEPDQRVSDAVDVRQELDLRIGAAFTRFQTLRLQRIFPEVLAEQLISYGSCQFPTLGFVVERFKAIQAFVPEIFHRIKVTHDHKDGIVEFNWKRHRLFNHTACLVLYQLCVEDPMATVVEVRSKPKSKWRPQALDTVELEKLASRKLRINAKETMRIAEKLYTQGYISYPRTETNIFPRDLNLTVLVEQQTPDPRWGAFAQSILERGGPTPRNGNKSDQAHPPIHPTKYTNNLQGDEQRLYEFIVRHFLACCSQDAQGQETTVEIDIAQERFVAHGLMILARNYLDVYPYDHWSDKILPVYEQGSHFQPSTVEMVDGETSPPKLLTEADLIALMEKHGIGTDATHAEHIETIKARMYVGLTPDKRFLPGHLGMGLVEGYDSMGYEMSKPDLRAELEADLKLICDGKKDKFVVLRQQVQKYKQVFIEAVAKAKKLDEALAQYFGNGTELAQQEDIYPAMPEPIRKCPQCNKDMVLKTKKNGGFYLSCMGFPECRSAVWLPDSVLEASRDSSVCPVCQPHPVYRLKLKFKRGSLPPTMPLEFVCCIGGCDDTLREILDLRFSGGPPRASQPSGRLQANQSLNRMDNSQHPQPADSRQTGSSKALAQTLPPPTAAGESNSVTCNCGQEAVLLTVRKEGPNRGRQFFKCNGGSCNFFLWADSPNPGAGGPPALAYRPLGASLGCPPGPGIHLGGFGNPGDGSGSGTSCLCSQPSVTRTVQKDGPNKGRQFHTCAKPREQQCGFFQWVDENTAPGTSGAPSWTGDRGRTLESEARSKRPRASSSDMGSTAKKPRKCSLCHQPGHTRPFCPQNR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 22 | Phosphorylation | RPEDRAFSRAAMEMA CHHHHHHHHHHHHHH | 21.74 | - | |
| 35 | Ubiquitination | MALRGVRKVLCVAEK HHHHHHCCEEEEECC | 36.83 | - | |
| 42 | Ubiquitination | KVLCVAEKNDAAKGI CEEEEECCCHHHHHH | 50.84 | - | |
| 47 | Ubiquitination | AEKNDAAKGIADLLS ECCCHHHHHHHHHHH | 53.20 | - | |
| 54 | Phosphorylation | KGIADLLSNGRMRRR HHHHHHHHCCHHHHH | 44.53 | 18669648 | |
| 66 | Ubiquitination | RRREGLSKFNKIYEF HHHHHHHHHHHHEEE | 58.98 | - | |
| 73 | Ubiquitination | KFNKIYEFDYHLYGQ HHHHHEEEEEEECCC | 6.75 | - | |
| 130 | Ubiquitination | PENFVDIKKTLERET CCCCCCHHHHHHHHH | 34.93 | - | |
| 162 | Ubiquitination | NIGFEIIHVCKAVKP CCCHHHHHHHHHCCC | 25.28 | - | |
| 168 | Ubiquitination | IHVCKAVKPNLQVLR HHHHHHCCCCHHHHH | 32.80 | - | |
| 226 | Ubiquitination | TRFQTLRLQRIFPEV HHHHHHHHHHHCHHH | 4.51 | - | |
| 232 (in isoform 2) | Ubiquitination | - | 39.14 | 21890473 | |
| 239 | Ubiquitination | EVLAEQLISYGSCQF HHHHHHHHHCCCCCC | 2.73 | - | |
| 250 | Ubiquitination | SCQFPTLGFVVERFK CCCCCCHHHHHHHHH | 18.77 | - | |
| 257 | Ubiquitination | GFVVERFKAIQAFVP HHHHHHHHHHHHHHH | 51.29 | 21890473 | |
| 257 (in isoform 1) | Ubiquitination | - | 51.29 | 21890473 | |
| 257 | Ubiquitination | GFVVERFKAIQAFVP HHHHHHHHHHHHHHH | 51.29 | 21890473 | |
| 258 | Ubiquitination | FVVERFKAIQAFVPE HHHHHHHHHHHHHHH | 9.09 | - | |
| 321 | Acetylation | VRSKPKSKWRPQALD EECCCCCCCCCCCCC | 54.04 | 25953088 | |
| 321 | Ubiquitination | VRSKPKSKWRPQALD EECCCCCCCCCCCCC | 54.04 | - | |
| 326 | Ubiquitination | KSKWRPQALDTVELE CCCCCCCCCCHHHHH | 15.30 | - | |
| 334 | Ubiquitination | LDTVELEKLASRKLR CCHHHHHHHHHCCCC | 63.08 | - | |
| 345 | Ubiquitination | RKLRINAKETMRIAE CCCCCCHHHHHHHHH | 49.59 | - | |
| 353 | Ubiquitination | ETMRIAEKLYTQGYI HHHHHHHHHHHCCCC | 37.46 | - | |
| 355 | Phosphorylation | MRIAEKLYTQGYISY HHHHHHHHHCCCCCC | 14.21 | 23663014 | |
| 356 | Phosphorylation | RIAEKLYTQGYISYP HHHHHHHHCCCCCCC | 26.42 | 23663014 | |
| 359 | Phosphorylation | EKLYTQGYISYPRTE HHHHHCCCCCCCCCC | 4.11 | 23663014 | |
| 361 | Phosphorylation | LYTQGYISYPRTETN HHHCCCCCCCCCCCC | 22.17 | 23663014 | |
| 362 | Phosphorylation | YTQGYISYPRTETNI HHCCCCCCCCCCCCC | 6.28 | 23663014 | |
| 421 | Ubiquitination | HPPIHPTKYTNNLQG CCCCCCCCCCCCCCC | 55.30 | - | |
| 451 | Ubiquitination | CCSQDAQGQETTVEI HHCCCCCCCEEEEEE | 29.07 | - | |
| 462 | Ubiquitination | TVEIDIAQERFVAHG EEEEEHHHHHHHHHH | 42.61 | - | |
| 498 | Phosphorylation | LPVYEQGSHFQPSTV ECCCCCCCCCCCCCE | 22.33 | 29116813 | |
| 503 | Phosphorylation | QGSHFQPSTVEMVDG CCCCCCCCCEEEECC | 34.01 | 29116813 | |
| 504 | Phosphorylation | GSHFQPSTVEMVDGE CCCCCCCCEEEECCC | 27.45 | 29116813 | |
| 507 | Ubiquitination | FQPSTVEMVDGETSP CCCCCEEEECCCCCC | 2.64 | - | |
| 513 | Phosphorylation | EMVDGETSPPKLLTE EEECCCCCCCCCCCH | 34.60 | 29116813 | |
| 529 | Ubiquitination | DLIALMEKHGIGTDA HHHHHHHHCCCCCCC | 32.92 | - | |
| 546 | Ubiquitination | AEHIETIKARMYVGL HHHHHHHHHHHCCCC | 37.04 | - | |
| 554 | Phosphorylation | ARMYVGLTPDKRFLP HHHCCCCCCCCCCCC | 24.42 | - | |
| 557 | Ubiquitination | YVGLTPDKRFLPGHL CCCCCCCCCCCCCCC | 46.37 | - | |
| 576 | Ubiquitination | VEGYDSMGYEMSKPD CCCCHHCCCCCCCCH | 21.14 | - | |
| 602 | Ubiquitination | ICDGKKDKFVVLRQQ EECCCCCEEEEEHHH | 49.27 | - | |
| 668 | Acetylation | CNKDMVLKTKKNGGF CCCCEEEEEEECCCE | 47.06 | 19826825 | |
| 669 | Phosphorylation | NKDMVLKTKKNGGFY CCCEEEEEEECCCEE | 42.99 | 20166139 | |
| 670 | Acetylation | KDMVLKTKKNGGFYL CCEEEEEEECCCEEE | 42.53 | 19826833 | |
| 671 | Ubiquitination | DMVLKTKKNGGFYLS CEEEEEEECCCEEEE | 67.09 | - | |
| 694 | Phosphorylation | SAVWLPDSVLEASRD CCEECCHHHHHHCCC | 27.02 | - | |
| 703 | Phosphorylation | LEASRDSSVCPVCQP HHHCCCCCCCCCCCC | 31.84 | - | |
| 760 | Phosphorylation | SGGPPRASQPSGRLQ CCCCCCCCCCCCCCC | 43.85 | 26714015 | |
| 771 | Phosphorylation | GRLQANQSLNRMDNS CCCCCCHHHHCCCCC | 27.67 | 25159151 | |
| 778 | Phosphorylation | SLNRMDNSQHPQPAD HHHCCCCCCCCCCCC | 26.12 | - | |
| 964 | Phosphorylation | TLESEARSKRPRASS CHHHHHHHCCCCCCC | 39.81 | - | |
| 970 | Phosphorylation | RSKRPRASSSDMGST HHCCCCCCCCCCCCC | 31.49 | 28176443 | |
| 971 | Phosphorylation | SKRPRASSSDMGSTA HCCCCCCCCCCCCCC | 29.40 | 28985074 | |
| 972 | Phosphorylation | KRPRASSSDMGSTAK CCCCCCCCCCCCCCC | 29.17 | 28176443 | |
| 976 | Phosphorylation | ASSSDMGSTAKKPRK CCCCCCCCCCCCCCC | 20.67 | 29083192 | |
| 977 | Phosphorylation | SSSDMGSTAKKPRKC CCCCCCCCCCCCCCC | 36.45 | 29083192 | |
| 985 | Phosphorylation | AKKPRKCSLCHQPGH CCCCCCCCCCCCCCC | 36.75 | 28152594 | |
| 993 | Phosphorylation | LCHQPGHTRPFCPQN CCCCCCCCCCCCCCC | 46.05 | 28152594 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TOP3A_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TOP3A_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TOP3A_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| BLM_HUMAN | BLM | physical | 11470874 | |
| BLM_HUMAN | BLM | physical | 11406610 | |
| RFA1_HUMAN | RPA1 | physical | 12724401 | |
| FANCA_HUMAN | FANCA | physical | 12724401 | |
| BLM_HUMAN | BLM | physical | 12724401 | |
| TERF2_HUMAN | TERF2 | physical | 18418389 | |
| RMI1_HUMAN | RMI1 | physical | 24509834 | |
| CHK1_HUMAN | CHEK1 | genetic | 27453043 | |
| BRCA2_HUMAN | BRCA2 | genetic | 27453043 | |
| WEE1_HUMAN | WEE1 | genetic | 27453043 | |
| PALB2_HUMAN | PALB2 | genetic | 27453043 | |
| RAD17_HUMAN | RAD17 | genetic | 27453043 | |
| L2GL1_HUMAN | LLGL1 | genetic | 27453043 | |
| MSH2_HUMAN | MSH2 | genetic | 27453043 | |
| NF1_HUMAN | NF1 | genetic | 27453043 | |
| RS11_HUMAN | RPS11 | genetic | 27453043 | |
| CDC73_HUMAN | CDC73 | genetic | 27453043 | |
| CDC6_HUMAN | CDC6 | genetic | 27453043 | |
| M3K4_HUMAN | MAP3K4 | genetic | 27453043 | |
| TITIN_HUMAN | TTN | genetic | 27453043 | |
| FUMH_HUMAN | FH | genetic | 27453043 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-54 AND SER-771, AND MASSSPECTROMETRY. | |